Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2022-07-22

EMA recommends approval of Imvanex for the prevention of monkeypox disease

View source ↗

Summary

EMA recommends approval of Imvanex for preventing monkeypox disease, signaling a new preventive indication for the vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Imvanex (Modified vaccinia Ankara (MVA-BN) vaccine)